Myeloma is the 17th most common cause of cancer death in the UK, accounting for 2% of all cancer deaths (2016).[1-3]
In males in the UK, myeloma is the 16th most common cause of cancer death (2% of all male cancer deaths). In females in the UK it is the 16th most common cause of cancer death (2% of all female cancer deaths).
54% of myeloma deaths in the UK are in males, and 46% are in females.
Myeloma mortality rates (European age-standardised
Myeloma (C90), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2016
|AS Rate - 95% LCL||6.1||4.7||4.8||5.5||6.0|
|AS Rate - 95% UCL||6.7||6.7||7.4||9.6||6.7|
|AS Rate - 95% LCL||4.0||3.1||2.9||2.9||3.9|
|AS Rate - 95% UCL||4.4||4.5||4.7||5.6||4.4|
|AS Rate - 95% LCL||4.9||4.0||4.1||4.5||4.9|
|AS Rate - 95% UCL||5.3||5.1||5.6||6.9||5.3|
- Data were provided by the Office for National Statistics on request, October 2017. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
- Data were provided by ISD Scotland on request, October 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
- Data were provided by the Northern Ireland Cancer Registry on request, December 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
About this data
Data is for UK, 2016, ICD-10 C90.